SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 29, 2026

AWHL

Aspira Women's Health Inc.
BULLISH
Impact 5/10
Horizonweeks Processed5mo ago
Insider cluster: 2 insiders, $32K total
Actionable Insight ▲ Bullish

While the dollar amount is small, the timing — three days after a strategic collaboration with Cleveland Clinic — suggests insider conviction in the deal's value. Monitor for additional insider buying, especially from C-suite, and for any material terms from the collaboration's Statements of Work.

DirectionBullish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
AWHL ▼ -50.00% at T+60d
LONG call ✗ call lost -50.00% · α vs SPY -51.23% · entry $0.5400 → $0.2700
Entry = T+0 close
May 29, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.14%
$0.5400
settled 5mo ago
T+5d
-22.22%
call -22.22% · α -19.47%
$0.4200
settled 5mo ago
T+20d
-24.96%
call -24.96% · α -23.66%
$0.4052
settled 4mo ago
T+60d
-50.00%
call -50.00% · α -51.23%
$0.2700
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Two directors at Aspira Women's Health purchased a total of $32K in shares on the same day at $0.45/share, three days after the company announced a collaboration agreement with Cleveland Clinic. The cluster is small relative to market cap but is amplified by the cross-filing context of a material agreement, suggesting insiders may have been informed of the deal's strategic value.

Key Financial Metrics

Direction
buying
Total Value
$32.0K
Insiders
2

Key Facts

  • Two directors purchased 72K shares total for $32K at $0.45/share on 2025-09-17
  • Purchases occurred 3 days after the 8-K filing of a Master Collaboration and License Agreement with Cleveland Clinic
  • Total value of $32K is approximately 0.01% of market cap (assuming ~$326M market cap), below the 0.1% materiality threshold
  • Both trades are open-market purchases (code P), not grants or tax withholdings
  • No C-suite executives participated in the cluster

Financial Impact

Insider purchases total $32K, a trivial amount relative to market cap

insider ownership

Risk Factors

  • Small dollar amount relative to market cap limits signal strength
  • No C-suite participation reduces informational value of the cluster
  • OTC listing may amplify volatility and reduce liquidity

Market Snapshot

Exchange
OTC
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
80% bullish (5 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-AWHL-1780085283043
6 reports for AWHL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AWHL — sortable, filterable
TypeNow
Jun 22, 2026
18w ago
8-K
BEARISH ★ 5/10
$0.4600 $0.2900▲ +36.96%▲ +39.17%$0.1388 (+69.83%)
Jun 9, 2026
20w ago
8-K
BEARISH ★ 6/10
$0.4300 $0.2786▲ +35.21%▲ +39.29%$0.1388 (+67.72%)
May 29, 2026
21w ago
Insider Cluster
BULLISH ★ 5/10
$0.5400 $0.2700▼ −50.00%▼ −51.23%$0.1388 (−74.30%)
May 26, 2026
22w ago
8-K
NEUTRAL ★ 4/10
$0.4600 $0.3100▼ −32.61%▼ −35.33%$0.1388 (−69.83%)
Apr 30, 2026
25w ago
8-K
NEUTRAL ★ 3/10
$0.3900 $0.3509▼ −10.03%▼ −13.09%$0.1388 (−64.41%)
Apr 28, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$0.4000 $0.4000· 0.00%▼ −4.11%$0.1388 (−65.30%)
Showing 6 of 6

US Market Status

Market Open — Closes in 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 29, 2026